Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/60803
Title: Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma
Authors: Ponci, Vitor [UNIFESP]
Silva, Rafael Cossi da [UNIFESP]
Santana, Fernanda Paula Roncon [UNIFESP]
Grecco, Simone dos Santos [UNIFESP]
Fortunato, Célia Regina Martinez
Oliveira, Maria Aparecida de
Tavares-de-Lima, Wothan
Olivo, Clarice Rosa
Tibério, Iolanda de Fátima Lopes Calvo
Gomes, Kaio de Souza
Prado, Carla Máximo [UNIFESP]
Lago, Joao Henrique Ghilardi
http://lattes.cnpq.br/1740478426977844
Keywords: Biseugenol
Mixed-granulocytic asthma
Airway responsiveness
Airway inflammation
Issue Date: 18-Nov-2020
Publisher: Prof. Dr. R. Daniel Little
Citation: Ponci V, Silva RC, Santana FPR, Grecco SS, Fortunato CRM, Oliveira MA, Tavares-de-Lima W, Olivo CR, Tibério IdFLC, Gomes KS, Prado CM, Lago JHG. Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma. Molecules. 2020; 25(22):5384. https://doi.org/10.3390/molecules25225384
Abstract: In the present work, the anti-inflammatory and antiasthmatic potential of biseugenol, isolated as the main component from n-hexane extract from leaves of Nectandra leucantha and chemically prepared using oxidative coupling from eugenol, was evaluated in an experimental model of mixed-granulocytic asthma. Initially, in silico studies of biseugenol showed good predictions for drug-likeness, with adherence to Lipinski’s rules of five (RO5), good Absorption, Distribution, Metabolism and Excretion (ADME) properties and no alerts for Pan-Assay Interference Compounds (PAINS), indicating adequate adherence to perform in vivo assays. Biseugenol (20 mg·kg−1) was thus administered intraperitoneally (four days of treatment) and resulted in a significant reduction in both eosinophils and neutrophils of bronchoalveolar lavage fluid in ovalbumin-sensitized mice with no statistical difference from dexamethasone (5 mg·kg−1). As for lung function parameters, biseugenol (20 mg·kg−1) significantly reduced airway and tissue damping in comparison to ovalbumin group, with similar efficacy to positive control dexamethasone. Airway hyperresponsiveness to intravenous methacholine was reduced with biseugenol but was inferior to dexamethasone in higher doses. In conclusion, biseugenol displayed antiasthmatic effects, as observed through the reduction of inflammation and airway hyperresponsiveness, with similar effects to dexamethasone, on mixed-granulocytic ovalbumin-sensitized mice
URI: https://repositorio.unifesp.br/handle/11600/60803
ISSN: 1420-3049
Other Identifiers: https://doi.org/10.3390/molecules25225384
Appears in Collections:Artigo

Files in This Item:
File Description SizeFormat 
MOLECULES biseugenol e asma - VITOR PONCI-2020-.pdfArtigo principal2.24 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.